Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.485 SEK | +5.66% | +6.48% | -7.27% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.27% | 42.66M | |
+26.30% | 44.96B | |
-0.72% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.51% | 26.08B | |
-21.27% | 19.03B | |
+6.07% | 12.75B | |
+28.53% | 12.06B | |
-3.32% | 11.75B |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Mendus Obtains US FDA's Fast Track Tag for Blood Cancer Therapy